89 results
Page 2 of 5
8-K
EX-99.1
5sabmpjhlbv1pp
4 Aug 22
Karyopharm Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
7:36am
8-K
EX-99.1
onew881
8 Feb 22
Karyopharm Reports Strong Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
8:16am
8-K
EX-99.1
1r5q70m v43193n
3 Nov 21
Karyopharm Reports Strong Third Quarter 2021 Financial Results and Provides Business
7:10am
8-K
EX-99.1
vkvizcd4se1
5 Aug 21
Karyopharm Reports Business Highlights and Second Quarter 2021 Financial Results
7:11am
8-K
EX-99.1
m7zi8cnvnbtc
3 May 21
Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
7:20am
8-K
EX-10.2
utv50 3dnxu7060si
3 May 21
Departure of Directors or Certain Officers
7:18am
8-K
EX-10.3
m1fuzooi67ugwhxmc86
3 May 21
Departure of Directors or Certain Officers
7:18am
8-K
EX-99.1
xs42rxp8pehns6m vn
11 Feb 21
Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress
7:13am
8-K
EX-99.1
ciejewx
11 Jan 21
Karyopharm Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Total Revenues and Provides Commercial Update
8:06am
8-K
EX-99.1
ccfeyybe1pmi5vrw
18 Dec 20
Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
11:58am
8-K
EX-99.1
tp9kc1j 307j08gjk
4 Aug 20
Karyopharm Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress
7:13am